Navid, F., Santana, V. M., Neel, M., McCarville, M. B., Shulkin, B. L., Wu, J., . . . Daw, N. C. (2017). A Phase II Trial Evaluating the Feasibility of Adding Bevacizumab to Standard Osteosarcoma Therapy. Int J Cancer.
Chicago-стиль цитированияNavid, Fariba, et al. "A Phase II Trial Evaluating the Feasibility of Adding Bevacizumab to Standard Osteosarcoma Therapy." Int J Cancer 2017.
MLA-цитированиеNavid, Fariba, et al. "A Phase II Trial Evaluating the Feasibility of Adding Bevacizumab to Standard Osteosarcoma Therapy." Int J Cancer 2017.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.